L02AE04 - Zoekresultaten

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

diphereline p.r. powder and solvent for prolonged-release suspension for injection

ipsen pharma, france - triptorelin - powder and solvent for prolonged-release suspension for injection - 22.5 mg,

Ierland - Engels - HPRA (Health Products Regulatory Authority)

decapeptyl sr, 3 mg powder and solvent for suspension for injection

ipsen pharmaceuticals limited - triptorelin - powder and solvent for suspension for injection - 3 milligram(s) - gonadotropin releasing hormone analogues; triptorelin

Ierland - Engels - HPRA (Health Products Regulatory Authority)

salvacyl, 11.25 mg powder and solvent for prolonged-release suspension for injection

ipsen pharmaceuticals limited - triptorelin - powder and solvent for prolonged-release suspension for injection - 11.25 milligram(s) - gonadotropin releasing hormone analogues; triptorelin

Australië - Engels - Department of Health (Therapeutic Goods Administration)

decapeptyl triptorelin acetate 100 micrograms/1 ml solution for injection in 1ml pre-filled syringe with integrated needle

ferring pharmaceuticals pty ltd - triptorelin acetate, quantity: 100 microgram (equivalent: triptorelin, qty 95.6 microgram/ml) - injection, solution - excipient ingredients: glacial acetic acid; water for injections; sodium chloride - decapeptyl 100 micrograms/1 ml is indicated for down-regulation and prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation for assisted reproductive technologies (art).,in clinical trials decapeptyl 100 micrograms/1 ml has been used in cycles where urinary and recombinant human follicle stimulating hormone (fsh) as well as human menopausal gonadotrophin (hmg) were used for stimulation.